Some pharmacological aspects of antimalarial drugs.
D000962:Antimalarials / Q000494:pharmacology* / Q000627:therapeutic use; D002738:Chloroquine / Q000378:metabolism; D003622:Dapsone / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D006801:Humans; D008288:Malaria / Q000188:drug therapy / Q000517:prevention & control; D010963:Plasmodium falciparum / Q000187:drug effects; D010966:Plasmodium vivax / Q000187:drug effects; D011319:Primaquine / Q000378:metabolism; D002727:Proguanil / Q000494:pharmacology; D011739:Pyrimethamine / Q000378:metabolism; D011796:Quinacrine / Q000378:metabolism; D011803:Quinine / Q000378:metabolism; D013449:Sulfonamides / Q000627:therapeutic use; D014295:Trimethoprim / Q000378:metabolism
D000962:Antimalarials; D013449:Sulfonamides; D002738:Chloroquine; D003622:Dapsone; D011803:Quinine; D014295:Trimethoprim; D011796:Quinacrine; D011319:Primaquine; D002727:Proguanil; D011739:Pyrimethamine